Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Wockhardt has decided to voluntarily recall all the remaining batches of 12-15 products that were manufactured in the Chikalthana and Waluj facilities prior to the...
FDA has invited public suggestions on the GDUFA programme and the features FDA should propose for the next programme
More than half of top 100 pharma companies yet to register
To market generic aripiprazole in multiple strengths and dosage forms to treat mental disorders
Designed for humid climates; to co-partner with Brazilian govt in early May
To focus on addressing challenges faced by project managers while handling projects in complex environments
Vardhan asks scientists at IACS to accept new challenges
More than 150 participants from different pharma companies participated
Delegates discuss India's potential in nutraceuticals at the event in Mumbai
Govt officials promote India as ‘Healthcare provider to the world’
Standalone revenue from operations stood at Rs 255.9 crores
Urges public to #AskPharma how developing countries can get ‘A FAIR SHOT’ when vaccine prices are being kept secret
India is examining whether to take up with WTO the EU’s suspension order for sale of about 700 generic drugs which were approved based on...
Invokana belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors
To develop a vaccine against visceral leishmaniasis
The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020
The investment will be made in two tranches
Eight therapies have outgrown the IPM growth and all therapies have double digit growths
Conference attended by regulatory affairs experts and pharma companies
As the Obama administration chalks out a plan to combat the growing menace of antibiotic resistance, Jim ‘o’ Neill who was appointed by Prime Minister...
The decision was taken by CCEA, chaired by Prime Minister Narendra Modi
Dr Reddy’s Laboratories and its subsidiary, Promius Pharma announced the filing of three 505(b)(2) New Drug Applications (NDAs) with the US Food and Drug Administration...
This facility is spread across an area of 30,000 sq ft and is equipped with a 98-bed facility
Don’t dilute Patent Act, blogs Swadeshi Jagaran Manch co-convenor
The generic drugs that would be made available at ‘Jan Aushadhi’ stores across the country would be made available at 20-30 per cent cost of...
To develop potential antimalarial therapy